EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 139 filers reported holding EPIZYME INC in Q1 2021. The put-call ratio across all filers is 15.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 191 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 191 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 191 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 191 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 191 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -71.4% | 191 | -66.5% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 571 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 571 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -35.7% | 571 | 0.0% | 0.00% | – |
| Q4 2019 | $14,000 | +133.3% | 571 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -14.3% | 571 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | +16.7% | 571 | +13.3% | 0.00% | – |
| Q1 2019 | $6,000 | +200.0% | 504 | +31.6% | 0.00% | – |
| Q4 2018 | $2,000 | -50.0% | 383 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 383 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 383 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | – | 383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |